Frans K Gorus

6PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersDecision makingGene expression (incl. microarray and other genome-wide approaches)Epigenetics (incl. genome methylation and epigenomics)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 11, 2025
Continuous glucose monitor metrics from five studies identify participants at risk for type 1 diabetes development.

Peter Calhoun, Charles Spanbauer, Andrea K Steck

|Feb 04, 2025
Repeated OGTT Versus Continuous Glucose Monitoring for Predicting Development of Stage 3 Type 1 Diabetes: A Longitudinal Analysis.

Aster K Desouter, Bart Keymeulen, Ursule Van de Velde

|Jan 09, 2023
CTLA4, SH2B3, and CLEC16A diversely affect the progression of early islet autoimmunity in relatives of Type 1 diabetes patients.

Julie Vandewalle, Aster K Desouter, Bart J Van der Auwera

|Aug 27, 2021
Genetic variation at ERBB3/IKZF4 and sexual dimorphism in epitope spreading in single autoantibody-positive relatives.

Julie Vandewalle, Bart J Van der Auwera, Henna Amin

|Feb 17, 2021
Insulitis in the pancreas of non-diabetic organ donors under age 25 years with multiple circulating autoantibodies against islet cell antigens.

Silke Smeets, Diedert Luc De Paep, Geert Stangé

|Nov 04, 2020
A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes.

Bart Keymeulen, André van Maurik, Dave Inman

Pageof 1

Frequent Collaborators

5 joint publications

Bart Keymeulen

4 joint publications

Pieter Gillard

4 joint publications

Aster K Desouter

3 joint publications

Christophe De Block